Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 4/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16233609 | 0.77 | CHRM2 (0.41) | ALDH1A1CHRM2CHRM1 | |
| SCHEMBL26112272 | 0.77 | MAPT (0.42) | MAPTALDH1A1HTTTDP1MAPK1 | |
| SCHEMBL12083995 | 0.72 | ALDH1A1 (0.44) | MAPTALDH1A1HTTTDP1KDM4E | |
| SCHEMBL26117627 | 0.71 | KMT2A (0.44) | MAPTALDH1A1HTTTDP1MAPK1 | |
| SCHEMBL26135113 | 0.70 | KMT2A (0.43) | MAPTALDH1A1HTTTDP1MAPK1 | |
| SCHEMBL26115241 | 0.70 | ALDH1A1 (0.47) | MAPTALDH1A1HTTTDP1MAPK1 | |
| SCHEMBL9560307 | 0.69 | CHRM2 (0.38) | ALDH1A1CHRM2CHRM1GAA | |
| SCHEMBL26134626 | 0.69 | KMT2A (0.42) | MAPTALDH1A1HTTTDP1MAPK1 | |
| SCHEMBL13606808 | 0.68 | CHRM2 (0.37) | ALDH1A1TDP1CHRM2CHRM1GAA | |
| SCHEMBL26116848 | 0.68 | KMT2A (0.41) | MAPTALDH1A1HTTTDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504693-A1 | FRAGRANCE AND FLAVOR MATERIALS | Takasago International Corporation (JP) | 2025-02-12 | — | — | EP | claimed |
| WO-2023196616-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2023-10-12 | — | — | WO | claimed |
| US-20250091984-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4504693-A1 | FRAGRANCE AND FLAVOR MATERIALS | Takasago International Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| WO-2023196616-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (USA) (US) | 2023-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091984-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAS2R5, TAS2R8, NISCH | MAPT 2431/4885ALDH1A1 261/4885HTT 3533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.